Skip to main content
. 2021 Jul 26;21:855. doi: 10.1186/s12885-021-08575-0

Table 1.

Demographics and clinical characteristics

Characteristic Exp. (n = 21) Cont. (n = 19) χ2/t (p)
Mean ± SD (range)
N (%)
Mean ± SD (range)
N (%)
Age (years) 49.86 ± 7.9 (34–67) 47.63 ± 6.96 (33–58) .937(.355)
 30–39 1 (4.8) 2 (10.5) 2.573 (.462)
 40–49 10 (47.6) 11 (57.9)
 50–59 8 (38.1) 6 (31.6)
 60–69 2 (9.5) 0 (0)
Marital status
 Married 15 (71.4) 12 (63.2) .311(.577)
 Unmarried 6 (28.6) 7 (36.8)
Monthly income, 10,000 KRW
  < 300 ($2,660) 11 (52.4) 9 (47.4) .100 (.752)
  ≥ 300 ($2,660) 10 (47.6) 10 (52.6)
(USD dollars)
 Employment status
  No 15 (71.4) 10 (52.6) 1.503(.220)
  Yes 6 (28.6) 9 (47.4)
 Education level
   < Middle school 1 (4.8) 1 (5.3) 3.713(.156)
  High school 14 (66.6) 7 (36.8)
   ≥ College 6 (28.6) 11 (57.9)
 Children
  No 5 (23.8) 4 (21.1) .043(.835)
  Yes 16 (76.2) 15 (78.9)
 Stage
  I 5 (23.8) 5 (26.3) 1.744(.418)
  II 12 (57.1) 13 (68.4)
  III 4 (19) 1 (5.3)
 Surgery type
  Mastectomy 4 (19) 5 (26.3) .302 (.583)
  Lumpectomy 17 (81) 14 (73.7)
 Time since diagnosis
   < 1 year 8 (38.1) 8 (42.1) .575(.750)
  1–2 years 11 (52.4) 8 (42.1)
   ≥ 2 years 2 (9.5) 3 (15.8)
 Chemotherapy
  None 0 (0) 1 (5.3) 1.134(.287)
  Past 21 (100) 18 (94.7)
 Radiation therapy
  None 1 (4.8) 3 (15.8) 1.206(.235)
  Past 20 (95.2) 16 (84.2)
 Endocrine therapy
  No 9 (42.9) 8 (42.1) .002(.962)
  Yes 12 (57.1) 11 (57.9)
 Targeted therapy
  No 10 (47.6) 15 (78.9) 4.483(.106)
  Yes 10 (47.6) 4 (21.1)
  Unknown 1 (4.8) 0 (0.0)

Abbreviations: Cont Control group, Exp Experimental group, KRW Korean won (1160 KRW = approximately 1 US)